Hepatitis B, Rituximab, Screening, and Prophylaxis: Effectiveness and Cost Effectiveness
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- September 10, 2012
has subject area
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Antibodies, Monoclonal, Murine-Derived (MeSH)
- Antineoplastic Combined Chemotherapy Protocols (MeSH)
- Cost-Benefit Analysis (MeSH)
- Cyclophosphamide (MeSH)
- Doxorubicin (MeSH)
- Early Diagnosis (MeSH)
- Hepatitis B (MeSH)
- Humans (MeSH)
- Lymphoma, Large B-Cell, Diffuse (MeSH)
- Oncology & Carcinogenesis (Science Metrix)
- Prednisone (MeSH)
- Rituximab (MeSH)
- Vincristine (MeSH)
published in
- Journal of Clinical Oncology Journal